Facial Skin Cancers (Basal Cell Carcinoma, Squamous Cell Carcinoma)

Facial skin cancers are among the most common malignancies affecting the head and neck region, with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) accounting for the majority of cases. These cancers typically arise due to chronic exposure to ultraviolet (UV) radiation, making sun-exposed areas of the face such as the nose, cheeks, eyelids, lips, and forehead particularly vulnerable.

Basal cell carcinoma is the most prevalent and generally slow-growing form of skin cancer. It often presents as a pearly nodule, non-healing ulcer, or translucent lesion with rolled margins. Although BCC rarely metastasizes, it can cause significant local tissue destruction if left untreated, especially on delicate facial structures.

Squamous cell carcinoma is more aggressive than BCC and arises from the keratinizing cells of the epidermis. Clinically, it may appear as a scaly plaque, ulcerated lesion, or firm nodule that may bleed or crust. SCC carries a higher risk of regional lymph node metastasis, particularly when occurring on the lips, ears, or in immunocompromised patients.

Early diagnosis through clinical examination and biopsy is critical for optimal outcomes. Management options include surgical excision, Mohs micrographic surgery, radiotherapy, and reconstructive procedures to restore facial form and function. Preventive strategies such as sun protection, regular skin surveillance, and early medical consultation play a vital role in reducing morbidity associated with facial skin cancers.